Our previous study demonstrated that MSCs-derived exosomes exert protective effects against liver fibrosis by delivering miR-148a to macrophages, which targets the KLF6/STAT3 pathway [18]. The gene discussed is STAT3; the disease is Hepatic fibrosis.